Helus Pharma announced Chief Medical Officer Amir Inamdar will participate in a fireside chat at the H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference on June 15-16, 2026. The chat will be available on demand starting June 15 at 7:00 a.m. EDT. Helus Pharma develops novel serotonergic agonists for mental health conditions.
Tap to vote and see what everyone thinks.